Sepsis knowledge survey across seven sub-Saharan African countries
Official title: African Survey on Sepsis Knowledge (ASK)
Run by Charite University, Berlin, Germany · NCT07351344 · Data updated 2026-11-12
This anonymous online survey asks healthcare workers in seven sub-Saharan African countries questions to see how much they know about sepsis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 1 site (Kumasi) |
| Status | Recruiting |
| Started | February 20, 2026 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | February 24, 2026 |
| Trial ID | NCT07351344 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult healthcare professionals or trainees employed in a healthcare facility in Uganda, Ethiopia, the Democratic Republic of the Congo, Mozambique, Ghana, Sierra Leone, or Nigeria who can complete the online survey in English or French are ideal participants.
✕Probably not a fit
People not employed in healthcare, healthcare workers outside the seven participating countries, those without internet or adequate language skills, or respondents who leave most questions unanswered are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The survey targets doctors, nurses, midwives and trainees working in partner institutions in Uganda, Ethiopia, the Democratic Republic of the Congo, Mozambique, Ghana, Sierra Leone, and Nigeria. It is conducted by the STAIRS network and will be run in two cross-sectional waves, with the baseline and a follow-up 12–24 months later to compare sepsis knowledge scores. Findings will be used to identify knowledge gaps and to shape webinars and an online learning platform for clinical capacity building. Participation is voluntary, anonymous, and requires internet access and sufficient English or French language skills.
Why it matters
Potential benefit: If successful, the project could pinpoint sepsis knowledge gaps and guide training that improves early recognition and treatment of sepsis.
How similar studies have gone: Similar clinician knowledge surveys and linked educational programs in other regions have improved sepsis awareness and practice, though large multi-country efforts in sub-Saharan Africa are relatively uncommon.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Occupation: adult members of a healthcare profession (e.g., doctors, nurses, midwifes) or their trainees * Place of work: employment in a healthcare facility in one of the seven partner countries (Uganda, Ethiopia, Democratic Republic of the Congo, Mozambique, Ghana, Sierra Leone, Nigeria). * Consent: Willingness to participate voluntarily in the anonymous online survey. Exclusion Criteria: * Not employed in a healthcare profession (e.g., administrative staff, non-medical professionals) * Not employed in one of the participating countries. Incomplete questionnaires (\< 50% of questions answered) * No internet access or technical limitations that make participation impossible. To complete the survey online. * Language skills: Sufficient language skills in the survey language (English or French)
Where it's running
-
The Komfo Anokye teaching hospital
Kumasi, Ghana Recruiting
Study contacts
- Study coordinator: Claudia Spies, MD, Prof.
- Email: claudia.spies@charite.de
- Phone: +49 30 450 55 11 02
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care
This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.
-
Early detection of sepsis-related blood clotting problems in severe burn patients
This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.
-
Neutrophil EMR3 as a biomarker for sepsis in ICU patients
Researchers will test whether measuring EMR3 on neutrophils helps diagnose sepsis, monitor progression, and predict outcomes in adults in Chinese ICUs.
-
Thymalfasin added to standard care for adults with sepsis and immune dysfunction
This study tests whether thymosin alpha-1 helps restore immune function in adults with sepsis who have weakened immunity.
-
Multicenter group study of sepsis and ARDS in China
This study tests how sepsis and ARDS differ among adults across several Chinese hospitals and builds a biobank to understand why some patients do better or worse.
-
Non-invasive hemodynamic guidance for sepsis care on medical wards
This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.